Xiaobin Wu - 23 Jun 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Signature
/s/ Qing Nian, as Attorney-in-Fact
Issuer symbol
ONC
Transactions as of
23 Jun 2025
Transactions value $
-$354,380
Form type
4
Filing time
25 Jun 2025, 17:08:54 UTC
Previous filing
18 Jun 2025
Next filing
15 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wu Xiaobin President and COO C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND /s/ Qing Nian, as Attorney-in-Fact 25 Jun 2025 0001739452

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONC American Depositary Shares Sale -$354K -1.36K -100% $260.00 0 23 Jun 2025 Direct F1, F2
holding ONC Ordinary Shares 1.23M 23 Jun 2025 Direct
holding ONC American Depositary Shares 12.4K 23 Jun 2025 Direct F1
holding ONC American Depositary Shares 4K 23 Jun 2025 By Wife F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents 13 Ordinary Shares.
F2 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.